Adam Januszewski

1.1k total citations
18 papers, 776 citations indexed

About

Adam Januszewski is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Adam Januszewski has authored 18 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Molecular Biology. Recurrent topics in Adam Januszewski's work include Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers) and Anesthesia and Neurotoxicity Research (2 papers). Adam Januszewski is often cited by papers focused on Estrogen and related hormone effects (3 papers), HER2/EGFR in Cancer Research (3 papers) and Anesthesia and Neurotoxicity Research (2 papers). Adam Januszewski collaborates with scholars based in United Kingdom, United States and Portugal. Adam Januszewski's co-authors include Daqing Ma, Yi Shu, Mervyn Maze, Mahmuda Hossain, Jing Xu, Pamela Sun, Robert D. Sanders, Sunil K. Halder, António Rei Fidalgo and Carlo Palmieri and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Anesthesiology.

In The Last Decade

Adam Januszewski

17 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Januszewski United Kingdom 8 480 379 368 97 79 18 776
John McCann United States 16 676 1.4× 481 1.3× 428 1.2× 94 1.0× 148 1.9× 30 1.3k
Chung-Sik Oh South Korea 14 125 0.3× 83 0.2× 139 0.4× 43 0.4× 113 1.4× 62 542
Birgit Roth Z’graggen Switzerland 14 162 0.3× 150 0.4× 130 0.4× 94 1.0× 60 0.8× 22 678
Martin Roesslein Germany 14 219 0.5× 120 0.3× 74 0.2× 195 2.0× 15 0.2× 20 601
Matthew D. Moravec United States 7 266 0.6× 137 0.4× 139 0.4× 85 0.9× 34 0.4× 7 962
Jin Deok Joo South Korea 13 50 0.1× 58 0.2× 107 0.3× 118 1.2× 59 0.7× 26 607
Andreas Redel Germany 17 273 0.6× 44 0.1× 99 0.3× 142 1.5× 198 2.5× 35 804
L J Bynum United States 9 227 0.5× 30 0.1× 69 0.2× 223 2.3× 29 0.4× 11 742
Jin Yong Jung South Korea 14 41 0.1× 53 0.1× 85 0.2× 69 0.7× 20 0.3× 47 516

Countries citing papers authored by Adam Januszewski

Since Specialization
Citations

This map shows the geographic impact of Adam Januszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Januszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Januszewski more than expected).

Fields of papers citing papers by Adam Januszewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Januszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Januszewski. The network helps show where Adam Januszewski may publish in the future.

Co-authorship network of co-authors of Adam Januszewski

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Januszewski. A scholar is included among the top collaborators of Adam Januszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Januszewski. Adam Januszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Quaife, Samantha L., Lucy Mitchinson, Zara Pogson, et al.. (2024). Understanding the impact of distance and disadvantage on lung cancer care and outcomes: a study protocol. BMC Cancer. 24(1). 942–942. 2 indexed citations
2.
Tipples, Karen, et al.. (2024). Simulation as an effective means of preparing trainees for active participation in MDT meetings. SHILAP Revista de lepidopterología. 11(1). 100017–100017. 2 indexed citations
3.
Hardavella, Georgia, Dimitrios E. Magouliotis, Roberto Chalela, et al.. (2024). Stage I and II nonsmall cell lung cancer treatment options. Breathe. 20(2). 230219–230219. 4 indexed citations
4.
Mitchinson, Lucy, Samantha L. Quaife, Zara Pogson, et al.. (2024). 207 Exploring the experiences of rural and coastal people with lung cancer and their informal carers' in accessing and engaging in treatment: A qualitative interview study. Lung Cancer. 190. 107768–107768. 1 indexed citations
5.
Zhang, Yu Zhi, Beatrice Gallo, Adam Januszewski, et al.. (2022). Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma. Cancers. 14(17). 4105–4105. 6 indexed citations
6.
Maher, Geoffrey J., Rosemary A. Fisher, Baljeet Kaur, et al.. (2022). Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours. npj Genomic Medicine. 7(1). 26–26. 6 indexed citations
7.
Januszewski, Adam, et al.. (2015). Transformation of oncology inpatients: effects on length of stay and patient satisfaction. PubMed. 2(3). 162–165. 1 indexed citations
8.
Palmieri, Carlo, Iain R. Macpherson, Felipe Ades, et al.. (2015). Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer. Oncotarget. 7(11). 13209–13220. 4 indexed citations
9.
Smirne, Carlo, G. Grossi, David J. Pinato, et al.. (2015). Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma. Digestive and Liver Disease. 47(6). 488–494. 34 indexed citations
10.
Januszewski, Adam & Justin Stebbing. (2014). Hyperthermia in cancer: is it coming of age?. The Lancet Oncology. 15(6). 565–566. 21 indexed citations
11.
Palmieri, Carlo, et al.. (2013). Breast cancer: Current and future endocrine therapies. Molecular and Cellular Endocrinology. 382(1). 695–723. 80 indexed citations
12.
Palmieri, Carlo, Vivek Misra, Adam Januszewski, et al.. (2013). Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer. Clinical Breast Cancer. 14(2). 85–93. 11 indexed citations
13.
Papadatos-Pastos, Dionysis, Adam Januszewski, & Angus Dalgleish. (2013). Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS. Expert Review of Anticancer Therapy. 13(5). 559–567. 5 indexed citations
14.
Krishna, Rajesh, C Hunt, Adam Januszewski, et al.. (2012). Impact of Hemochromatosis Gene (HFE) Polymorphisms and Iron Overload on Outcome of Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 18(2). S210–S210.
15.
Palmieri, Carlo, et al.. (2011). Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer. Expert Review of Anticancer Therapy. 11(2). 179–183. 37 indexed citations
16.
Krell, Jonathan, et al.. (2011). Role of fulvestrant in the management of postmenopausal breast cancer. Expert Review of Anticancer Therapy. 11(11). 1641–1652. 7 indexed citations
17.
Sanders, Robert D., Jing Xu, Yi Shu, et al.. (2009). Dexmedetomidine Attenuates Isoflurane-induced Neurocognitive Impairment in Neonatal Rats. Anesthesiology. 110(5). 1077–1085. 342 indexed citations
18.
Ma, Daqing, Peter J. Williamson, Adam Januszewski, et al.. (2007). Xenon Mitigates Isoflurane-induced Neuronal Apoptosis in the Developing Rodent Brain. Anesthesiology. 106(4). 746–753. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026